This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Ascending colon (controls excluding all cancers)
CD2_BENIGN_ASCENDING_COLON_EXALLC
No definition available.
Endpoint definition
↥individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
3177
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Benign neoplasm: Ascending colon (controls excluding all cancers) based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Ascending colon
- Benign neoplasm: Colon (controls excluding all cancers)
- Benign neoplasm: Colon
- Benign neoplasm of colon, rectum, anus and anal canal
- Benign neoplasm of colon, rectum, anus and anal canal (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 3177 | 1537 | 1640 |
Unadjusted prevalence (%) | 0.84 | 0.73 | 0.99 |
Mean age at first event (years) | 66.58 | 64.97 | 68.09 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_ASCENDING_COLON_EXALLC – Benign neoplasm: Ascending colon (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Ascending colon (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.